Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Responding to a surge in overdose deaths: perspectives from US syringe services programs.
Frost MC, Austin EJ, Corcorran MA, Briggs ES, Behrends CN, Juarez AM, Frank ND, Healy E, Prohaska SM, LaKosky PA, Kapadia SN, Perlman DC, Schackman BR, Des Jarlais DC, Williams EC, Glick SN. Frost MC, et al. Among authors: briggs es. Harm Reduct J. 2022 Jul 19;19(1):79. doi: 10.1186/s12954-022-00664-y. Harm Reduct J. 2022. PMID: 35854351 Free PMC article.
Syringe Service Program Perspectives on Barriers, Readiness, and Programmatic Needs to Support Rollout of the COVID-19 Vaccine.
Corcorran MA, Austin EJ, Behrends CN, Briggs ES, Frost MC, Juarez AM, Frank ND, Healy E, Prohaska SM, LaKosky PA, Kapadia SN, Perlman DC, Schackman BR, Des Jarlais DC, Williams EC, Glick SN. Corcorran MA, et al. Among authors: briggs es. J Addict Med. 2023 Jan-Feb 01;17(1):e36-e41. doi: 10.1097/ADM.0000000000001036. Epub 2022 Aug 2. J Addict Med. 2023. PMID: 35916422 Free PMC article.
Barriers to engaging people who use drugs in harm reduction services during the COVID-19 pandemic: A mixed methods study of syringe services program perspectives.
Austin EJ, Corcorran MA, Briggs ES, Frost MC, Behrends CN, Juarez AM, Frank ND, Healy E, Prohaska SM, LaKosky PA, Kapadia SN, Perlman DC, Schackman BR, Jarlais DCD, Williams EC, Glick SN. Austin EJ, et al. Among authors: briggs es. Int J Drug Policy. 2022 Nov;109:103825. doi: 10.1016/j.drugpo.2022.103825. Epub 2022 Aug 10. Int J Drug Policy. 2022. PMID: 35977459 Free PMC article.
Integrating Opioid Use Disorder Treatment Into Primary Care Settings.
Austin EJ, Chen J, Briggs ES, Ferro L, Barry P, Heald A, Merrill JO, Curran GM, Saxon AJ, Fortney JC, Ratzliff AD, Williams EC. Austin EJ, et al. Among authors: briggs es. JAMA Netw Open. 2023 Aug 1;6(8):e2328627. doi: 10.1001/jamanetworkopen.2023.28627. JAMA Netw Open. 2023. PMID: 37566414 Free PMC article.
Optimizing Patient Engagement in Treatment for Opioid Use Disorder: Primary Care Team Perspectives on Influencing Factors.
Austin EJ, Chen J, Soyer E, Idrisov B, Briggs ES, Ferro L, Saxon AJ, Fortney JC, Curran GM, Moghimi Y, Blanchard BE, Williams EC, Ratzliff AD, Ruiz MS, Koch U. Austin EJ, et al. Among authors: briggs es. J Gen Intern Med. 2024 Dec;39(16):3196-3204. doi: 10.1007/s11606-024-08963-9. Epub 2024 Jul 29. J Gen Intern Med. 2024. PMID: 39073482
"New Normal:" Opportunities and Challenges Faced by Syringe Service Programs Following the Effects of the COVID-19 Pandemic.
Austin EJ, Briggs ES, Corcorran MA, Chen J, Cotta N, Behrends CN, Prohaska SM, LaKosky PA, Kapadia SN, Perlman DC, Schackman BR, Des Jarlais DC, Williams EC, Glick SN. Austin EJ, et al. Among authors: briggs es. Subst Use Misuse. 2025 Jan 14:1-8. doi: 10.1080/10826084.2024.2447411. Online ahead of print. Subst Use Misuse. 2025. PMID: 39810391
13 results